![]() |
Name |
Ueckerchalasin D
|
Molecular Formula | C30H39NO5 | |
IUPAC Name* |
[5-hydroxy-16-[hydroxy(phenyl)methyl]-5,7,13,14-tetramethyl-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9,12-trien-2-yl]acetate
|
|
SMILES |
CC(=O)OC1C=CC(C)(O)CC(C)CC=CC2C=C(C)C(C)C3C(C(O)c4ccccc4)NC(=O)C213
|
|
InChI |
InChI=1S/C30H39NO5/c1-18-10-9-13-23-16-19(2)20(3)25-26(27(33)22-11-7-6-8-12-22)31-28(34)30(23,25)24(36-21(4)32)14-15-29(5,35)17-18/h6-9,11-16,18,20,23-27,33,35H,10,17H2,1-5H3,(H,31,34)/b13-9+,15-14+/t18-,20+,23-,24+,25-,26+,27-,29-,30+/m0/s1
|
|
InChIKey |
GQJTZUBHCMVKGA-IJWFZUFLSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 493.64 | ALogp: | 4.3 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 95.9 | Aromatic Rings: | 4 |
Heavy Atoms: | 36 | QED Weighted: | 0.415 |
Caco-2 Permeability: | -4.901 | MDCK Permeability: | 0.00003680 |
Pgp-inhibitor: | 0.453 | Pgp-substrate: | 0.143 |
Human Intestinal Absorption (HIA): | 0.132 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.006 |
Blood-Brain-Barrier Penetration (BBB): | 0.944 | Plasma Protein Binding (PPB): | 92.98% |
Volume Distribution (VD): | 1.585 | Fu: | 8.14% |
CYP1A2-inhibitor: | 0.018 | CYP1A2-substrate: | 0.183 |
CYP2C19-inhibitor: | 0.39 | CYP2C19-substrate: | 0.689 |
CYP2C9-inhibitor: | 0.365 | CYP2C9-substrate: | 0.293 |
CYP2D6-inhibitor: | 0.088 | CYP2D6-substrate: | 0.124 |
CYP3A4-inhibitor: | 0.911 | CYP3A4-substrate: | 0.577 |
Clearance (CL): | 2.376 | Half-life (T1/2): | 0.026 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.028 |
Drug-inuced Liver Injury (DILI): | 0.271 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.469 | Maximum Recommended Daily Dose: | 0.258 |
Skin Sensitization: | 0.016 | Carcinogencity: | 0.026 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.928 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001922 | ![]() |
0.782 | D05VQI | ![]() |
0.316 | ||
ENC004542 | ![]() |
0.650 | D0O5WP | ![]() |
0.280 | ||
ENC004444 | ![]() |
0.636 | D02HSB | ![]() |
0.272 | ||
ENC004468 | ![]() |
0.610 | D06CWH | ![]() |
0.269 | ||
ENC002763 | ![]() |
0.597 | D0C4RB | ![]() |
0.268 | ||
ENC002261 | ![]() |
0.587 | D0O5SZ | ![]() |
0.252 | ||
ENC003653 | ![]() |
0.587 | D0M6VK | ![]() |
0.252 | ||
ENC005440 | ![]() |
0.584 | D04LHJ | ![]() |
0.250 | ||
ENC005441 | ![]() |
0.581 | D0E9KA | ![]() |
0.248 | ||
ENC002762 | ![]() |
0.579 | D06VFO | ![]() |
0.248 |